Subscribe
m-a-istock-523159870_in-focus
in-focus / iStockphoto.com
13 June 2018Americas

Life sciences analytics providers combine in $195m deal

Clinical technology company Medidata has bought Shyft Analytics, a cloud data analytics platform, for $195 million.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Bayer completes acquisition of Monsanto
7 June 2018   German life sciences company Bayer has completed the $66 billion buyout of agricultural corporation Monsanto, a week after the US government announced Bayer must divest $9 billion worth of assets for the deal to proceed.
Big Pharma
GSK buys out Novartis in $13bn consumer healthcare deal
27 March 2018   GSK has revealed that it will buy Novartis out of their joint consumer healthcare business.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Big Pharma
GSK buys out Novartis in $13bn consumer healthcare deal
27 March 2018   GSK has revealed that it will buy Novartis out of their joint consumer healthcare business.
Americas
Bayer completes acquisition of Monsanto
7 June 2018   German life sciences company Bayer has completed the $66 billion buyout of agricultural corporation Monsanto, a week after the US government announced Bayer must divest $9 billion worth of assets for the deal to proceed.

More on this story

Big Pharma
GSK buys out Novartis in $13bn consumer healthcare deal
27 March 2018   GSK has revealed that it will buy Novartis out of their joint consumer healthcare business.
Americas
Bayer completes acquisition of Monsanto
7 June 2018   German life sciences company Bayer has completed the $66 billion buyout of agricultural corporation Monsanto, a week after the US government announced Bayer must divest $9 billion worth of assets for the deal to proceed.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent